Ted Slocomb
About Ted Slocomb
Ted Slocomb serves as the VP of Global Marketing at Kite Pharma, where he has worked since 2021. He possesses over 25 years of experience in the biopharmaceutical industry, with a focus on gene and cell therapy, corporate development, and commercial planning.
Work at Kite Pharma
Ted Slocomb has been serving as the Vice President of Global Marketing at Kite Pharma since 2021. In this role, he is responsible for overseeing the marketing strategies for the company's gene and cell therapy products. His leadership contributes to Kite Pharma's mission to advance innovative therapies for cancer treatment. The company is based in Santa Monica, California, where Slocomb has been instrumental in shaping the global marketing approach for Kite's portfolio.
Education and Expertise
Ted Slocomb holds a Bachelor of Arts degree in Genetics from the University of California, Berkeley, which he completed from 1984 to 1988. He also earned a Master of Business Administration (MBA) in Finance from NYU Stern School of Business between 1991 and 1993. His educational background supports his extensive expertise in strategic global commercial leadership within the biopharmaceutical sector, particularly in gene and cell therapy.
Background
With over 25 years of experience in the biopharmaceutical industry, Ted Slocomb has developed a strong foundation in launch planning, marketing, strategic partnering, and financing of both novel small molecule and biopharmaceutical products. His career includes significant roles at various companies, including Amylin Pharmaceuticals, Astellas Gene Therapies, and Fate Therapeutics Inc. This diverse background has equipped him with a comprehensive understanding of corporate development and commercial planning.
Previous Positions
Prior to his current role at Kite Pharma, Ted Slocomb held several key positions in the biopharmaceutical industry. He worked at Astellas Gene Therapies from 2015 to 2021, where he served as Vice President of Commercial Planning and Global Market Access. Before that, he was the Global Commercial Leader for MYALEPT at Amylin Pharmaceuticals from 2006 to 2013. His experience also includes roles at Fate Therapeutics Inc and Ortho-McNeil Pharmaceutical, where he focused on new product commercialization and corporate development.
Achievements
Throughout his career, Ted Slocomb has played a pivotal role in the commercialization of various biopharmaceutical products. His leadership in marketing and strategic planning has contributed to successful product launches and market access strategies. While specific achievements are not detailed, his extensive experience in the industry highlights his capability in driving growth and innovation within the biopharmaceutical sector.